Indian Govt Lifts Export Ban on Anti-malarial Drug Hydroxychloroquine

India has lifted the export ban on hydroxychloroquine, an anti-malarial drug with immediate effect. On March 25, the government banned the export of the drug due to the outbreak of the COVID-19 pandemic.

The Centre had imposed curbs on the export of Hydroxychloroquine and formulations used to manufacture the medicine.

‘India is a major exporter of Hydroxychloroquine drug, which has witnessed a surge in demand amid the novel COVID-19 crisis. ’

According to a late-night notification by the Ministry of Commerce and Industry, the export status of the medication and the composition ingredients have been changed from "prohibited" to "free."

The notification was issued by the Directorate General of Foreign Trade (DGFT).

Source: IANS